These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1864700)

  • 21. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease.
    Ganz P; Heidecker B; Hveem K; Jonasson C; Kato S; Segal MR; Sterling DG; Williams SA
    JAMA; 2016 Jun; 315(23):2532-41. PubMed ID: 27327800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil.
    Barros ZM; de Alencar Ximenes RA; Miranda-Filho DB; de Albuquerque Mde F; Melo HR; Carvalho EH; Gelenske T; Diniz G; Bandeira F
    Metab Syndr Relat Disord; 2010 Dec; 8(6):489-97. PubMed ID: 20973693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the risk of coronary heart disease I. The use of conventional risk markers.
    Dent TH
    Atherosclerosis; 2010 Dec; 213(2):345-51. PubMed ID: 20637467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is a rapid review? A methodological exploration of rapid reviews in Health Technology Assessments.
    Harker J; Kleijnen J
    Int J Evid Based Healthc; 2012 Dec; 10(4):397-410. PubMed ID: 23173665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some alternative perspectives concerning medical technology assessment.
    Diamond GA
    J Invasive Cardiol; 1992; 4(1):39-44. PubMed ID: 10149903
    [No Abstract]   [Full Text] [Related]  

  • 26. QRS interval fails to predict coronary disease incidence. The Framingham Study.
    Kreger BE; Anderson KM; Levy D
    Arch Intern Med; 1991 Jul; 151(7):1365-8. PubMed ID: 2064487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary Artery Calcium Distribution Is an Independent Predictor of Incident Major Coronary Heart Disease Events: Results From the Framingham Heart Study.
    Ferencik M; Pencina KM; Liu T; Ghemigian K; Baltrusaitis K; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
    Circ Cardiovasc Imaging; 2017 Oct; 10(10):. PubMed ID: 28956774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthcare Databases in Thailand and Japan: Potential Sources for Health Technology Assessment Research.
    Saokaew S; Sugimoto T; Kamae I; Pratoomsoot C; Chaiyakunapruk N
    PLoS One; 2015; 10(11):e0141993. PubMed ID: 26560127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
    Koenig W; Löwel H; Baumert J; Meisinger C
    Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using medical registries and data sets for technology assessment.
    Antczak-Bouckoms A; Burdick E; Klawansky S; Mosteller F
    Int J Technol Assess Health Care; 1991; 7(2):123-8. PubMed ID: 1864695
    [No Abstract]   [Full Text] [Related]  

  • 31. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study.
    D'Agostino RB; Belanger AJ; Kannel WB; Cruickshank JM
    BMJ; 1991 Aug; 303(6799):385-9. PubMed ID: 1912805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community surveillance for coronary heart disease: the Framingham Cardiovascular Disease survey. Comparisons with the Framingham Heart Study and previous short-term studies.
    Margolis JR; Gillum RF; Feinleib M; Brasch R; Fabsitz R
    Am J Cardiol; 1976 Jan; 37(1):61-7. PubMed ID: 942677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study.
    Wilson PW; Anderson KM; Castelli WP
    Am J Med; 1991 Jan; 90(1):11-6. PubMed ID: 1986576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Health registries: methodological issues].
    Bruzzi P
    Recenti Prog Med; 2015 Sep; 106(9):436-43. PubMed ID: 26418505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score.
    Balady GJ; Larson MG; Vasan RS; Leip EP; O'Donnell CJ; Levy D
    Circulation; 2004 Oct; 110(14):1920-5. PubMed ID: 15451778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Framingham Study].
    Yoshinari M
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():381-6. PubMed ID: 11347099
    [No Abstract]   [Full Text] [Related]  

  • 37. Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort.
    Vergnaud AC; Bertrais S; Galan P; Hercberg S; Czernichow S
    Prev Med; 2008 Jul; 47(1):61-5. PubMed ID: 18456313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health technology news. Assessing effectiveness: databases can help.
    Menon D
    Dimens Health Serv; 1991 Apr; 68(3):8-9. PubMed ID: 1894091
    [No Abstract]   [Full Text] [Related]  

  • 39. II. Coronary Heart Disease in the Framingham Study.
    Dawber TR; Moore FE; Mann GV
    Int J Epidemiol; 2015 Dec; 44(6):1767-80. PubMed ID: 26705414
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular Event Prediction and Risk Reclassification by Coronary, Aortic, and Valvular Calcification in the Framingham Heart Study.
    Hoffmann U; Massaro JM; D'Agostino RB; Kathiresan S; Fox CS; O'Donnell CJ
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26903006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.